gvtcx

NHS National Pharmaceuticals Transition 2019_1 - Contracts Finder Award Notice

NHS England Published 7 May 2019 Contracts Finder

key details

Value£28,656,720
Statuscomplete
Category (CPV) 33600000 +1 more
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline7 Jun 2019
Contract start1 Oct 2019
Contract end28 Feb 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-05f22a4a-856c-4c7c-8b7f-7969e70f59e0

Award

SupplierValueDateStatus
Please see list of awarded suppliers (including SME status) at t £28,656,720 1 Aug 2019 active

description

NHS National Pharmaceuticals Transition 2019_1

Offer reference number: CM/PHG/17/5547

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 34 months

Potential periods of call-offs under the framework agreement:

LSNE: 01/10/2019 to 30/04/2020 (7 months)

CESW: 01/10/2019 to 30/09/2020 (12 months)

NWLN: 01/10/2019 to 28/02/2021 (17 months)

Awarded product list

bortezomib, arsenic, darunavir, atazanavir, ritonavir, miglustat, gefitinib, carglumic acid, clofaribine, ganciclovir, aprepitant, dexmedetomidine, solifenacin, atomoxetine, atovaquone, metaraminol and olopatadine

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
26 Sept 2019 Award (award) · a7ac8d77-95ca-425e-bf54-e7bc1954bddf-316108

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.